Advertisement

Manitoba agrees to purchase 2M doses of Providence Therapeutics coronavirus vaccine

Click to play video: 'Manitoba to buy Canadian-made COVID-19 vaccine doses upon approval' Manitoba to buy Canadian-made COVID-19 vaccine doses upon approval
WATCH: Manitoba to buy Canadian-made COVID-19 vaccine doses upon approval – Feb 11, 2021

The Manitoba government has committed to buy two million doses of a made-in-Canada COVID-19 vaccine currently under clinical trial.

Premier Brian Pallister announced the purchase of the Providence Therapeutics COVID-19 vaccine at a Thursday morning press conference.

Click to play video: 'Coronavirus: Manitoba agrees to purchase 2M doses of Providence Therapeutics COVID-19 vaccine' Coronavirus: Manitoba agrees to purchase 2M doses of Providence Therapeutics COVID-19 vaccine
Coronavirus: Manitoba agrees to purchase 2M doses of Providence Therapeutics COVID-19 vaccine – Feb 11, 2021

Read more: Coronavirus: Manitoba ramping up to deliver 20,000 vaccine doses a day by April

Story continues below advertisement

“With today’s announcement we’re taking a big step … to creating a secure, stable supply of Canadian-made COVID vaccines,” Pallister said.

A human trial for the prospective vaccine was started in Toronto in late January.

In a release Jan. 26 Providence said the vaccine, dubbed PTX-COVID19-B, is a messenger RNA (mRNA) vaccine, and is the first fully-made in Canada vaccine to reach the human clinical trial stage.

Click to play video: 'Coronavirus: Pallister blasts federal government over lack of made-in-Canada COVID-19 vaccines' Coronavirus: Pallister blasts federal government over lack of made-in-Canada COVID-19 vaccines
Coronavirus: Pallister blasts federal government over lack of made-in-Canada COVID-19 vaccines – Feb 11, 2021

The company says subjects in the trial will be monitored for 13 months, but enough data should be gathered by April to move to a second phase of testing by May, pending regulatory approval.

With positive results, Providence Therapeutics has said it expects commercialization of the vaccine to begin by the end of 2021 or early 2022.

Story continues below advertisement

Pallister said the province’s agreement with Alberta-based Providence, called a term sheet, will see Manitoba receiving the first 200,000 doses of the vaccine as soon as it is approved for sale in Canada.

Read more: Coronavirus: Manitoba launches online COVID-19 vaccine queue calculator

He said the agreement includes a “best-price guarantee” that means the province won’t pay more than any other government for the vaccine.

Pallister wouldn’t say exactly how much the province has agreed to pay, but did say the agreement will see Manitoba putting 20 per cent down, with another 40 per cent coming on approval by Health Canada and the final 40 per cent coming on delivery.

“We’ll release the details of the contract when it’s finalized,” he said.

Story continues below advertisement

If the vaccine is approved for sale, a government release said the drug product manufacturing and filling of vials with vaccine is planned to be done by Emergent BioSolutions, at its manufacturing facility in Winnipeg.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

“Manitobans are Canadians first. We are investing not just for ourselves, but for all Canadians,” said Pallister.

Read more: 1,200 additional coronavirus vaccine doses available for Manitoba First Nations: health officials

“Building a secure, made-in-Canada vaccine supply will put Canadians at the head of the line to get a COVID vaccine, where we belong.”

The province says the Providence vaccine is similar to those made by Pfizer and Moderna, which have shown to be more adaptive to variants of the COVID-19 virus.

Click to play video: 'UK coronavirus variant confirmed in Manitoba' UK coronavirus variant confirmed in Manitoba
UK coronavirus variant confirmed in Manitoba – Feb 9, 2021

Providence’s chief executive officer said the company has been talking with other provinces as well.

Story continues below advertisement

“The provinces are very keen to have security of supply. They’re very keen to see this made in Canada,” Brad Sorenson said.

Sorenson has asked the federal government for a similar deal but has not received an answer.

Read more: Coronavirus: Delay in shipments leads Manitoba to plan fewer COVID-19 vaccinations

The company wants $150 million from Ottawa to pay for the clinical trials and material costs. In exchange, Providence would offer Canada a 30 per cent discount on market prices and priority access to vaccines that may be needed for variants and booster shots.

Pallister said he wrote to the prime minister and other premiers Thursday to invite them to join the initiative. He said he didn’t expect any trouble from Ottawa for securing a provincial deal.

“Surely they wouldn’t stand in the way of provinces who have, throughout our history, been responsible for delivering health care,” Pallister said.

Click to play video: 'Parents, advocacy groups say Manitoba’s vaccine priority list leaves out high risk young adults' Parents, advocacy groups say Manitoba’s vaccine priority list leaves out high risk young adults
Parents, advocacy groups say Manitoba’s vaccine priority list leaves out high risk young adults – Feb 11, 2021

Manitoba’s Opposition New Democrats said they are worried the deal could fall through and pointed to problems the Progressive Conservative government has run into rolling out vaccines and testing sites.

Story continues below advertisement

But they support the initiative.

“We need domestic vaccine production capability here in Canada and, if this helps to accomplish that, then I think that that’s something we should welcome and support,” NDP Leader Wab Kinew said.

Read more: Parents, advocacy groups say Manitoba’s vaccine priority list leaves out high-risk young adults

COVID-19 cases in Manitoba have dropped in recent weeks following a spike in the fall. Health officials reported 90 new cases and three deaths Thursday.

The demand on hospital intensive care units continues to drop as well.

For the first time since November, the number of people in intensive care beds for all health conditions this week has dropped below 100.

20,000 doses a day by April

On Wednesday, the province announced it is expanding eligibility for COVID-19 immunizers to include athletic therapists, chiropractors, dental hygienists, massage therapists, and optometrists on the list of those qualified to give the shot.

The move means 17 different professions can now administer the coronavirus vaccine.

Read more: 70 per cent of Manitobans expected to be vaccinated for COVID-19 this year: projection

Story continues below advertisement

The province said it’s ramping up in an effort to be ready to deliver up to 20,000 shots a day by April.

Delays in deliveries of both the Pfizer and Moderna vaccine have forced the province to scale back vaccination efforts for the time being.

Click to play video: 'Questions over province’s vaccine priority list' Questions over province’s vaccine priority list
Questions over province’s vaccine priority list – Feb 10, 2021

Manitoba’s current capacity is 7,499 doses per day, the province said Wednesday.

Since January, 66,090 doses of vaccine have been delivered to Manitoba, including 43,290 doses of Pfizer vaccine, and 22,800 doses of the Moderna vaccine.

Read more: Pop-up coronavirus vaccination site opens for priority First Nation members in Winnipeg

To date, 50,554 doses of vaccine have been administered in Manitoba, including 33,930 first doses and 16,624 second doses, according to provincial data.

Story continues below advertisement

The province said Wednesday it expects to receive 3,510 doses of Pfizer this week and another 15,210 doses next week.

—With files from Steve Lambert at The Canadian Press

Questions about COVID-19? Here are some things you need to know:

Symptoms can include fever, cough and difficulty breathing — very similar to a cold or flu. Some people can develop a more severe illness. People most at risk of this include older adults and people with severe chronic medical conditions like heart, lung or kidney disease. If you develop symptoms, contact public health authorities.

To prevent the virus from spreading, experts recommend frequent handwashing and coughing into your sleeve. They also recommend minimizing contact with others, staying home as much as possible and maintaining a distance of two metres from other people if you go out. In situations where you can’t keep a safe distance from others, public health officials recommend the use of a non-medical face mask or covering to prevent spreading the respiratory droplets that can carry the virus. In some provinces and municipalities across the country, masks or face coverings are now mandatory in indoor public spaces.

Story continues below advertisement

For full COVID-19 coverage from Global News, click here.

Sponsored content